52 NORTH HEALTH LTD
ActiveKey figures
Like most small UK companies, 52 NORTH HEALTH LTD does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.
Ratios
2025Sector comparison
SIC 72110Where the company stands among the 3,991 active companies whose first SIC code is 72110 (Research and experimental development on biotechnology).
- BRACCO HORIZONS LIMITED£526.1m
- TAURX THERAPEUTICS MANAGEMENT LTD.£470.3m
- LABCORP EARLY DEVELOPMENT LABORATORIES LIMITED£317m
- JAZZ PHARMACEUTICALS RESEARCH UK LIMITED£289.2m
- GENOME RESEARCH LIMITED£273.7m
- MODERNA BIOTECH UK LIMITED£236.5m
- CURIA (SCOTLAND) LIMITED£183m
- ASTEX THERAPEUTICS LIMITED£163.6m
- HORIZON DISCOVERY GROUP LIMITED£159.6m
- AMGEN LIMITED£134.4m
Positions are approximate. Figures come from each company's latest accounts; money and employee figures are compared only with companies that filed accounts in pounds for a period ending in the last two and a half years and are not dormant, so those groups are smaller than 3,991. The line on each bar marks the median.
Summary: 52 NORTH HEALTH LTD
What kind of company is it?
52 NORTH HEALTH LTD is a private limited company registered with Companies House under company number 11460425. It was incorporated on 11 Jul 2018. Its status is active. The registered office is in Barleythorpe (LE15). Its nature of business (SIC 2007) is research and experimental development on biotechnology (72110), other professional, scientific and technical activities n.e.c. (74909).
How is the company doing financially?
The latest accounts in the database are for 2025 (period ending 31 Dec 2025); the company files small company accounts (filleted). Net assets were £2,731,957, down 22.3% on the previous year. Cash at bank and in hand was £2,149,914. The company had an average of 18 employees. Figures are available for 5 financial years (2021–2025).
How does it compare with similar companies?
Compared with 3,991 active companies whose first SIC code is 72110: By net assets it ranks higher than 89% of them (median £20,587). By total assets it ranks higher than 83% of them (median £124,497). By cash it ranks higher than 84% of them (median £101,426). By number of employees it ranks higher than 93% of them (median 1). It is older than 66% of them (median age 5.4 years).
Has it received government grants?
It is recorded as the recipient of 4 central government grants worth £163.7k, mainly from Department for Science, Innovation and Technology.
What do public registers and reports show?
HMRC lists it as an importer of goods, mainly machinery, optical, medical and measuring instruments.
Who runs and controls the company?
The company has 7 current directors.
When are its next filings due?
The next accounts are due by 30 Sep 2027. The next confirmation statement is due by 7 Mar 2027.
Filed accounts2021–2025
| 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Cash at bank and in hand | 869,769 | 1,093,921 | 579,050 | 3,543,071 | 2,149,914 |
| Total assets | 1,225,708 | 1,259,976 | 985,778 | 3,789,666 | 2,854,317 |
| Total liabilities | 286,825 | 293,118 | 200,233 | — | — |
| Net assets / total equity | 938,883 | 966,858 | 785,545 | 3,514,898 | 2,731,957 |
| Average number of employees | 3 | 7 | 9 | 12 | 18 |
A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.
Government grants
4 grants52 NORTH HEALTH LTD is recorded as the recipient of 4 central government grants since 2022, together worth £163.7k.
- Department for Science, Innovation and Technology
- 2 grants · £138.6k
- Department for Business, Energy and Industrial Strategy
- 1 grant · £24.5k
- Department for International Trade
- 1 grant · £500
- UK Tradeshow Programme 2022-23Department for International Trade · £500
- Development of the NeutroCheck diagnostic device to enable remote triage of chemotherapy patients at risk of neutropenic sepsisDepartment for Science, Innovation and Technology · £111,572 · UKRI - Innovate UK - Scheme
- Development of the NeutroCheck diagnostic device to enable remote triage of chemotherapy patients at risk of neutropenic sepsisDepartment for Business, Energy and Industrial Strategy · £24,533 · UKRI - Innovate UK - Scheme 22/23
- University of Cambridge and 52 North Health Limited KTP 21-22 R4Department for Science, Innovation and Technology · £27,050 · UKRI - Innovate UK - Scheme
From the Government Grants Register published by the Cabinet Office (financial years 2016/17 onwards, Open Government Licence v3.0). It covers grants from central government departments and their agencies where the register states the recipient's company number and the recipient name matches this company; grants from local authorities, lottery distributors and devolved governments are not included.
Registers and licences
Listed by HMRC as an importer of goods in 3 of the last 12 months on record, most recently August 2026. Main goods: machinery and optical, medical and measuring instruments.
From HMRC's monthly lists of importers and exporters. Traders can ask to be left off the lists, so absence does not mean a company does not trade.
Sources: Charity Commission for England and Wales, Care Quality Commission, Home Office and HM Revenue & Customs, under the Open Government Licence v3.0. Entries marked ‡ come from lists that do not state a company number and were linked by an exact match on the registered name.
History
30 events- Felix Peter Heinrich LITZKOW appointedDirector
- Patrik BÄCHTIGER appointedDirector
- Tim IRISH resignedDirector
- Financial year 2025 endedAccounts: net assets £2.7m, 18 employees
- David John JEANS appointedDirector
- Financial year 2024 endedAccounts: net assets £3.5m, 12 employees
- Mrs Umaima Ahmad ceased to be a person with significant control
- Leszek Krzysztof BORYSIEWICZ resignedDirector
Earlier events (22)
- Amanda Clare WOODING resignedDirector
- Karim GALZAHR appointedDirector
- Nirdesh GUPTA appointedDirector
- Tim IRISH appointedDirector
- Financial year 2023 endedAccounts: net assets £785.5k, 9 employees
- Mrs Umaima Ahmad registered as a person with significant control
- Dr Syed Saif Ahmad ceased to be a person with significant control
- Financial year 2022 endedAccounts: net assets £966.9k, 7 employees
- Leszek Krzysztof BORYSIEWICZ appointedDirector
- Financial year 2021 endedAccounts: net assets £938.9k, 3 employees
- Amanda Clare WOODING appointedDirector
- Mrs Umaima Ahmad ceased to be a person with significant control
- Name changed to 52 NORTH HEALTH LTDPreviously NEUTROCHECK LTD
- Fahad Riyadh Tahseen Ali ceased to be a person with significant control
- Fahad Riyadh Tahseen ALI resignedDirector
- Syed Saif AHMAD appointedDirector
- Umaima AHMAD appointedDirector
- Fahad Riyadh Tahseen ALI appointedDirector
- Dr Syed Saif Ahmad registered as a person with significant control
- Mrs Umaima Ahmad registered as a person with significant control
- Fahad Riyadh Tahseen Ali registered as a person with significant control
- Company incorporatedPrivate limited company
Dates as recorded at Companies House: incorporation, name changes, officer appointments and resignations, current and former persons with significant control, and the end of each financial year with figures in the database.